{"data":{"id":"us-tx/tex.-health-and-safety-code-491.054","jurisdiction":"us-tx","citation":"Tex. Health and Safety Code § 491.054","heading":"COMMISSION SELECTION.","body":"The commission, in the commission's sole discretion, shall select a consortium established in accordance with Section 491.051 for the purpose of conducting ibogaine drug development clinical trials under this subchapter.\nAdded by Acts 2025, 89th Leg., R.S., Ch. 333 (S.B. 2308), Sec. 1, eff. June 11, 2025.","path":["HEALTH AND SAFETY CODE","TITLE 6. FOOD, DRUGS, ALCOHOL, AND HAZARDOUS SUBSTANCES","SUBTITLE C. SUBSTANCE ABUSE REGULATION AND CRIMES Chapter 491, consisting of Secs. 491.001 to 491.103, was added by Acts 2025, 89th Leg., R.S., Ch. 333 (S.B. 2308), Sec. 1. For another Chapter 491, consisting of Secs. 491.001 to 491.151, added by Acts 2025, 89th Leg., R.S., Ch. 285 (S.B. 984), Sec. 1, see Sec. 491.001 et seq., post. For another Chapter 491, consisting of Secs. 491.001 to 491.151, added by Acts 2025, 89th Leg., R.S., Ch. 352 (S.B. 670), Sec. 2, see Sec. 491.001 et seq., post.","CHAPTER 491. IBOGAINE TREATMENT","SUBCHAPTER B. DRUG DEVELOPMENT OF IBOGAINE TREATMENT"],"source_url":"https://statutes.capitol.texas.gov/Docs/HS/htm/HS.491.htm#491.054","current_through":"89th 2nd Called Legislative Session, 2025","vintage":"","retrieved_at":"2026-08-27T01:47:17Z","sha256":"cb9ab133001cee8c12bb40f0bc127038cf1af40270ad68ab8e0af8cc7ad8ce25","source_id":"us-tx","stale":false,"prev":"us-tx/tex.-health-and-safety-code-491.053","next":"us-tx/tex.-health-and-safety-code-491.055"},"notice":"GroundRules: Original legal text. Not legal advice."}